COVID-19 UPDATE: Firm Operations Continue Uninterrupted. Free Virtual Consultations Available. Click Here.
ACCIDENT NEWS

1 Killed in Crash on Interstate 280 Near Highway 87


Sedan Crashes in Fatal San Jose Accident

San Jose, CA (May 2, 2020) – One person was killed in a solo-vehicle crash in San Jose. The fatal accident occurred on the morning of May 2 on Interstate 280.

A sedan collided in the northbound lanes of Interstate 280, near Highway 87. Emergency crews removed the driver and passenger from the wreckage. The passenger was taken to a local hospital, while the driver died at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of the victim. 

#San Jose

#95125


June 4, 2020

Pedestrian Killed in Crash on Highway 101 Near San Martin Avenue

Good Samaritan Tried to Help Motorist Before Fatal San Martin Accident...


August 10, 2020

Man Killed in Crash at South Wilmington Avenue and Glenn Curtiss Street

Victim Dies in Fatal Carson Accident...


May 28, 2020

Worker Killed in Construction Accident at Monte Vista High School

Man Dies in Fatal Spring Valley Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


September 21, 2020

Lawsuit: ‘Tens Of Thousands’ Of Elmiron Patients At Risk For Vision Loss

A lawsuit filed on September 8 claims that “tens of thousands” of Elmiron patients were put at risk and hurt as a result of Janssen Pharmaceuticals’ conduct.


September 21, 2020

Lawsuit Claims Gilead Made ‘Unlawful’ Payment Over Truvada Competition

A lawsuit filed on Thursday claims that Gilead made an “unlawful” payment to Cipla in exchange for Cipla’s agreement to not compete against Truvada. The complaint states the payment “likely” came in the form of a license to produce Atripla, a license to produce Hepatitis C drugs in India or both.